Breaking News: GTH latest news.

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	Genetron says early liver cancer screening research results cited in guidelines » 07:30 02/09/21 02/09 07:30 02/09/21 07:30 GTH Genetron $28.23 / +0.74 (+2.69%) Genetron announced that… Genetron announced that its early liver cancer screening research results were cited by the "Chinese Anti-Cancer Association Guidelines for Patients with Primary Liver Cancer". The guidelines, issued by the Chinese Anti-Cancer Association, are the first national-level patient-oriented full-process guidelines for liver cancer prevention and treatment in China. In the section on early liver cancer screening, the guidelines emphasized that "Liquid biopsies based on circulating tumor DNA (ctDNA) have shown significant value in early screening for liver cancer. The combined detection of mutation and methylation, in combination with traditional protein biomarkers can achieve better screening results." The liquid biopsy-based early liver cancer screening study, jointly published by Genetron Health and the National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences in the Proceedings of the National Academy of Sciences, or PNAS, was cited in the guidelines indicating awareness and regard for Genetron's research among the expert community. ShowHide Related Items >><< Company News Street Research Syndicate On The Fly GTH Genetron $28.23 / +0.74 (+2.69%) 01/06/21 Genetron, CTTQ enter exclusive partnership agreement for HCCscreen 11/27/20 Genetron says HCCscreen selected by NCC, Wuxi for public health initiative 10/22/20 Genetron signs licensing agreement with ImmuQuad Bio for residual cancer assays 09/30/20 Genetron receives Breakthrough Device designation for NGS test HCCscreen GTH Genetron $28.23 / +0.74 (+2.69%) 09/30/20 Canaccord Genetron China opportunity understated with current valuation, says Canaccord 08/03/20 Canaccord Genetron outlook positive ahead of results, says Canaccord 07/14/20 BTIG Genetron initiated with a Buy at BTIG 19 Jun GTH Genetron $28.23 / +0.74 (+2.69%) 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/30/20 Fly Intel: Wall Street's top stories at midday

Over a month ago
Conference/Events	Genetron management to meet virtually with BTIG » 05:55 01/20/21 01/20 05:55 01/20/21 05:55 GTH Genetron $23.34 / +3.13 (+15.49%) Virtual Meetings to be… Virtual Meetings to be held January 19-20 hosted by BTIG. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events GTH Genetron $23.34 / +3.13 (+15.49%) 01/06/21 Genetron, CTTQ enter exclusive partnership agreement for HCCscreen 11/27/20 Genetron says HCCscreen selected by NCC, Wuxi for public health initiative 10/22/20 Genetron signs licensing agreement with ImmuQuad Bio for residual cancer assays 09/30/20 Genetron receives Breakthrough Device designation for NGS test HCCscreen GTH Genetron $23.34 / +3.13 (+15.49%) 09/30/20 Canaccord Genetron China opportunity understated with current valuation, says Canaccord 08/03/20 Canaccord Genetron outlook positive ahead of results, says Canaccord 07/14/20 BTIG Genetron initiated with a Buy at BTIG GTH Genetron $23.34 / +3.13 (+15.49%) 08/06/20 Genetron reports Q2 adjusted EPS (4c), consensus (9c) 19 Jun GTH Genetron $23.34 / +3.13 (+15.49%) 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/30/20 Fly Intel: Wall Street's top stories at midday 01/20/21 Genetron
Conference/Events	Genetron management to meet virtually with BTIG » 04:55 01/19/21 01/19 04:55 01/19/21 04:55 GTH Genetron $20.15 / -1.12 (-5.27%) Virtual Meetings to be… Virtual Meetings to be held January 19-20 hosted by BTIG. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events GTH Genetron $20.15 / -1.12 (-5.27%) 01/06/21 Genetron, CTTQ enter exclusive partnership agreement for HCCscreen 11/27/20 Genetron says HCCscreen selected by NCC, Wuxi for public health initiative 10/22/20 Genetron signs licensing agreement with ImmuQuad Bio for residual cancer assays 09/30/20 Genetron receives Breakthrough Device designation for NGS test HCCscreen GTH Genetron $20.15 / -1.12 (-5.27%) 09/30/20 Canaccord Genetron China opportunity understated with current valuation, says Canaccord 08/03/20 Canaccord Genetron outlook positive ahead of results, says Canaccord 07/14/20 BTIG Genetron initiated with a Buy at BTIG GTH Genetron $20.15 / -1.12 (-5.27%) 08/06/20 Genetron reports Q2 adjusted EPS (4c), consensus (9c) 19 Jun GTH Genetron $20.15 / -1.12 (-5.27%) 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/30/20 Fly Intel: Wall Street's top stories at midday 01/19/21 Genetron 01/20/21 Genetron
Conference/Events	Genetron management to meet virtually with BTIG » 10:57 01/15/21 01/15 10:57 01/15/21 10:57 GTH Genetron $20.38 / -0.89 (-4.18%) Virtual Meetings to be… Virtual Meetings to be held January 19-20 hosted by BTIG. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events GTH Genetron $20.38 / -0.89 (-4.18%) 01/06/21 Genetron, CTTQ enter exclusive partnership agreement for HCCscreen 11/27/20 Genetron says HCCscreen selected by NCC, Wuxi for public health initiative 10/22/20 Genetron signs licensing agreement with ImmuQuad Bio for residual cancer assays 09/30/20 Genetron receives Breakthrough Device designation for NGS test HCCscreen GTH Genetron $20.38 / -0.89 (-4.18%) 09/30/20 Canaccord Genetron China opportunity understated with current valuation, says Canaccord 08/03/20 Canaccord Genetron outlook positive ahead of results, says Canaccord 07/14/20 BTIG Genetron initiated with a Buy at BTIG GTH Genetron $20.38 / -0.89 (-4.18%) 08/06/20 Genetron reports Q2 adjusted EPS (4c), consensus (9c) 19 Jun GTH Genetron $20.38 / -0.89 (-4.18%) 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/30/20 Fly Intel: Wall Street's top stories at midday 01/19/21 Genetron 01/20/21 Genetron
On The Fly	Fly Intel: Wall Street's top stories for Wednesday » 16:32 01/06/21 01/06 16:32 01/06/21 16:32 MRNA Moderna $116.27 / +7.25 (+6.65%) , CHA China Telecom $28.85 / +0.33 (+1.16%) , CHU China Unicom $6.13 / -0.02 (-0.33%) , CHL China Mobile $27.70 / -1.65 (-5.62%) , BABA Alibaba $227.58 / -12.84 (-5.34%) , TCEHY Tencent $0.00 / + (+0.00%) , ABC AmerisourceBergen $106.15 / +8.43 (+8.63%) , WBA Walgreens Boots Alliance $43.05 / +1.89 (+4.59%) , UNH UnitedHealth $359.37 / +14.85 (+4.31%) , CHNG Change Healthcare $23.72 / +5.475 (+30.01%) , TSLA Tesla $756.20 / +20.72 (+2.82%) , DKNG DraftKings $49.00 / +1.45 (+3.05%) , GTH Genetron $15.66 / +2.01 (+14.73%) , DNMR Danimer Scientific $24.85 / +2.2 (+9.71%) , IMRA Imara $14.69 / -9.05 (-38.12%) , NEO NeoGenomics $51.35 / -3.47 (-6.33%) Stock futures were mostly… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options WBA UNH TSLA TCEHY NEO MRNA IMRA GTH DNMR DKNG CHU CHNG CHL CHA BABA ABC WBA Walgreens Boots Alliance $43.05 / +1.89 (+4.59%) 01/06/21 Walgreens expects to complete admin. of vaccine first doses in SNF by Jan. 25 12/28/20 CA Governor announces partnership with CVS, Walgreens to provide COVID vaccines 12/22/20 Pharmacy stocks lower after DoJ files prescription drug suit against Walmart UNH UnitedHealth $359.37 / +14.85 (+4.31%) 01/06/21 Change Healthcare jumps 37% to $25.10 after agreeing to merge with UnitedHealth 01/06/21 UnitedHealth's Optum to acquire Change Healthcare for $25.75 per share in cash 01/06/21 UnitedHealth's Optum to acquire Change Healthcare for $25.75 per share in cash 01/04/21 CVS Health up 1% after Amazon-Berkshire-JPMorgan JV said to disband TSLA Tesla $756.20 / +20.72 (+2.82%) 01/05/21 Tesla up 2% at $750.93 after Morgan Stanley price target increase to Street-high 01/03/21 Fly Intel: Top five weekend stock stories 01/03/21 Tesla reports 499,550 deliveries for 2020, slightly missing target 12/28/20 Elon Musk in Hawaii to 'seek some advice' from Larry Ellison TCEHY Tencent $0.00 / + (+0.00%) 01/06/21 Digital video game sales rose 12% y/y to $126.6B in 2020, says SuperData 12/18/20 Tencent Music consortium exercises option to acquire additional 10% of UMG 12/11/20 November video game spending rose 35% y/y to $7B, says NPD 11/12/20 NPD says U.S. video game consumer spending reached $11.2B in Q3 NEO NeoGenomics $51.35 / -3.47 (-6.33%) 01/05/21 NeoGenomics falls 6% to $51.57 after equity offering 11/18/20 NeoGenomics' Hipp sells 70,000 common shares 10/13/20 NeoGenomics to expand global footprint in pharma services MRNA Moderna $116.27 / +7.25 (+6.65%) 01/06/21 Moderna sees first deliveries of vaccine to European countries next week 01/06/21 Moderna announces CMA from European Commission for Covid-19 vaccine 01/06/21 EMA recommends Moderna's COVID-19 vaccine for authorization in the EU 01/04/21 FDA continues to recommend authorized COVID vaccine dosing schedule IMRA Imara $14.69 / -9.05 (-38.12%) 01/06/21 Imara reports Phase 2a trial results of IMR-687 in SCD 12/07/20 Imara presents IMR-687 Phase 2a OLE case reports 11/30/20 Imara to present clinical data on IMR-687 at ASH Annual Meeting 11/17/20 Imara appoints Lynette Hopkinson as SVP, regulatory GTH Genetron $15.66 / +2.01 (+14.73%) 01/06/21 Genetron, CTTQ enter exclusive partnership agreement for HCCscreen 11/27/20 Genetron says HCCscreen selected by NCC, Wuxi for public health initiative 10/22/20 Genetron signs licensing agreement with ImmuQuad Bio for residual cancer assays 09/30/20 Genetron receives Breakthrough Device designation for NGS test HCCscreen DNMR Danimer Scientific $24.85 / +2.2 (+9.71%) 12/29/20 Live Oak completes business combination, changes name to Danimer Scientific DKNG DraftKings $49.00 / +1.45 (+3.05%) 01/06/21 New York seeking proposals for mobile sports wagering operator 01/06/21 Cuomo seeks 'different model for sports betting' where state gets the sales 12/30/20 Kerrisdale Capital says FuboTV trades at valuation 'unmoored from reality' 12/29/20 Nevada reports November statewide gaming win down 17.75% to $771.16M CHU China Unicom $6.13 / -0.02 (-0.33%) 01/05/21 China Unicom rises 16.1% 01/05/21 China Unicom rises 18.1% CHNG Change Healthcare $23.72 / +5.475 (+30.01%) 11/30/20 Change Healthcare sells Capacity Management business to HealthStream CHL China Mobile $27.70 / -1.65 (-5.62%) 01/04/21 uCloudlink, China Mobile continue mobile connectivity partnership 11/19/20 Blue Hat Interactive signs cooperation agreement with China Mobile CHA China Telecom $28.85 / +0.33 (+1.16%) 01/06/21 NYSE to move forward with delisting China Telecom, China Mobile, China Unicom 01/05/21 NYSE to no longer delist China Mobile, China Unicom, China Telecom 12/31/20 China Unicom, China Mobile, China Telecom to be delisted by NYSE 11/12/20 Executive order issued on U.S. investment financing 'Chinese military companies' BABA Alibaba $227.58 / -12.84 (-5.34%) 01/06/21 Alibaba down 5% to $228.11 after report U.S. considering adding to stock ban 01/05/21 Alibaba to shut down music streaming app Xiami 12/27/20 Fly Intel: Top five weekend stock stories 12/27/20 Alibaba upsizes share repurchase program to $10B ABC AmerisourceBergen $106.15 / +8.43 (+8.63%) 01/06/21 AmerisourceBergen to acquire Alliance Healthcare from Walgreens for $6.5B 11/09/20 AmerisourceBergen names Dr. Lonie Haynes as Chief Diversity & Inclusion Office 11/06/20 AmerisourceBergen reaches agreement with CDC over pharmacy vaccine access 11/05/20 AmerisourceBergen sees FY21 CapEx ~$400M MRNA CHA CHU CHL BABA TCEHY ABC WBA UNH CHNG TSLA DKNG GTH DNMR IMRA NEO MRNA Moderna $116.27 / +7.25 (+6.65%) 01/06/21 Piper Sandler Moderna price target raised to $170 after EU vaccine approval at Piper Sandler 01/04/21 Piper Sandler Moderna shares warrant 'fresh look' after 41% pullback, says Piper Sandler 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg 12/29/20 Citi Arcturus selloff brings 'very good' buying opportunity, says Citi CHA China Telecom $28.85 / +0.33 (+1.16%) 03/24/20 CLSA China Telecom upgraded to Outperform from Underperform at CLSA 03/24/20 Macquarie China Telecom upgraded to Outperform from Neutral earlier at Macquarie CHU China Unicom $6.13 / -0.02 (-0.33%) 09/30/20 Nomura China Unicom upgraded to Buy from Neutral at Nomura 03/23/20 Macquarie China Unicom upgraded to Outperform from Neutral at Macquarie 03/23/20 Credit Suisse China Unicom upgraded to Outperform from Neutral at Credit Suisse 03/23/20 Credit Suisse China Unicom upgraded to Outperform from Neutral at Credit Suisse CHL China Mobile $27.70 / -1.65 (-5.62%) 07/13/20 New Street China Mobile downgraded to Reduce from Neutral at New Street 03/19/20 New Street China Mobile upgraded to Buy from Reduce at New Street BABA Alibaba $227.58 / -12.84 (-5.34%) 12/29/20 Truist Truist lowers Alibaba SOTP valuation but believes that break-up is unlikely 12/28/20 UBS Pinduoduo, JD could benefit if Alibaba forced to be less aggressive, says UBS 12/24/20 Raymond James Raymond James remains buyer of Alibaba, thinks antitrust worries priced in 12/24/20 Loop Capital iQIYI price target lowered to $18 from $25 at Loop Capital TCEHY Tencent $0.00 / + (+0.00%) 01/05/21 New Street Tencent named a top idea for 2021 at New Street 01/05/21 Jefferies Yeahka initiated with a Buy at Jefferies 12/15/20 Credit Suisse Prosus initiated with an Outperform at Credit Suisse ABC AmerisourceBergen $106.15 / +8.43 (+8.63%) 01/07/21 Deutsche Bank AmerisourceBergen price target raised to $115 from $111 at Deutsche Bank 01/06/21 BofA AmerisourceBergen upgraded to Neutral from Underperform at BofA 11/18/20 Jefferies Drug distributors' pullback on Amazon news an overreaction, says Jefferies 11/17/20 Goldman Sachs Goldman says Amazon news likely to pressure entire pharmacy supply chain WBA Walgreens Boots Alliance $43.05 / +1.89 (+4.59%) 01/05/21 Truist Walgreens Boots Alliance price target raised to $44 from $40 at Truist 12/04/20 Credit Suisse Walgreens leverage buyout math 'could still work,' says Credit Suisse 11/17/20 Oppenheimer Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer UNH UnitedHealth $359.37 / +14.85 (+4.31%) 01/07/21 Cowen Change Healthcare downgraded to Market Perform from Outperform at Cowen 01/07/21 Deutsche Bank UnitedHealth price target raised to $404 from $359 at Deutsche Bank 01/07/21 RBC Capital Change Healthcare downgraded to Sector Perform from Outperform at RBC Capital 01/07/21 Citi Change Healthcare downgraded to Neutral from Buy at Citi CHNG Change Healthcare $23.72 / +5.475 (+30.01%) 01/07/21 Truist Change Healthcare downgraded to Hold from Buy at Truist TSLA Tesla $756.20 / +20.72 (+2.82%) 01/07/21 RBC Capital upgraded Tesla to Sector Perform, re-evaluates its position in EV 01/07/21 RBC Capital Tesla upgraded to Sector Perform from Underperform at RBC Capital 01/07/21 Deutsche Bank BMW downgraded to Hold from Buy at Deutsche Bank 01/06/21 Credit Suisse Credit Suisse upgrades Li Auto to Outperform on sales momentum, autonomous plans DKNG DraftKings $49.00 / +1.45 (+3.05%) 01/07/21 Piper Sandler Penn National price target raised to $100 from $84 at Piper Sandler 01/06/21 Morgan Stanley New York sports betting comments hint at higher tax rate, says Morgan Stanley 01/06/21 Oppenheimer 'A live NY' enables DraftKings to execute national ad strategy, says Oppenheimer 12/18/20 BofA DraftKings price target raised to $60 from $55 at BofA GTH Genetron $15.66 / +2.01 (+14.73%) 09/30/20 Canaccord Genetron China opportunity understated with current valuation, says Canaccord 08/03/20 Canaccord Genetron outlook positive ahead of results, says Canaccord 07/14/20 BTIG Genetron initiated with a Buy at BTIG DNMR Danimer Scientific $24.85 / +2.2 (+9.71%) 01/06/21 Jefferies Danimer Scientific initiated with a Buy at Jefferies IMRA Imara $14.69 / -9.05 (-38.12%) 01/06/21 SVB Leerink Imara selloff a potential buying opportunity, says SVB Leerink 08/17/20 Fly Intel: Top five analyst upgrades 08/17/20 Citi Imara upgraded to Buy from Neutral at Citi 06/30/20 Citi Imara downgraded to Neutral from Buy at Citi NEO NeoGenomics $51.35 / -3.47 (-6.33%) 12/11/20 BTIG NeoGenomics initiated with a Buy at BTIG 11/20/20 SVB Leerink NeoGenomics price target raised to $50 from $47 at SVB Leerink 10/28/20 Needham NeoGenomics price target raised to $46 from $39 at Needham 10/28/20 Craig-Hallum NeoGenomics price target raised to $50 from $42 at Craig-Hallum WBA UNH TSLA TCEHY NEO MRNA IMRA GTH DKNG CHNG BABA ABC WBA Walgreens Boots Alliance $43.05 / +1.89 (+4.59%) 01/06/21 Notable companies reporting before tomorrow's open 10/15/20 Walgreens Boots Alliance sees FY21 adj. EPS up low single-digits 10/15/20 Walgreens Boots Alliance reports Q4 adj. EPS $1.02, consensus 96c 10/14/20 Notable companies reporting before tomorrow's open UNH UnitedHealth $359.37 / +14.85 (+4.31%) 12/01/20 UnitedHealth sees FY21 adjusted EPS $17.75-$18.25, consensus $18.33 12/01/20 UnitedHealth raises FY20 adj. EPS view to approach $16.75 from $16.50-$16.75 10/14/20 UnitedHealth raises FY20 adj. EPS view to $16.50-$16.75 from $16.25-$16.55 10/14/20 UnitedHealth reports Q3 adj. EPS $3.51, consensus $3.09 TSLA Tesla $756.20 / +20.72 (+2.82%) 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 07/22/20 Tesla reports Q2 adjusted EPS 50c, consensus (11c) 07/22/20 Notable companies reporting after market close TCEHY Tencent $0.00 / + (+0.00%) 10/28/20 Fly Intel: What to watch in Spotify earnings report NEO NeoGenomics $51.35 / -3.47 (-6.33%) 10/27/20 NeoGenomics reports Q3 EPS 4c, consensus 4c 07/28/20 NeoGenomics reports Q2 EPS (6c), consensus (10c) MRNA Moderna $116.27 / +7.25 (+6.65%) 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 10/28/20 Notable companies reporting before tomorrow's open 08/05/20 Moderna reports Q2 EPS (31c), consensus (35c) IMRA Imara $14.69 / -9.05 (-38.12%) 11/05/20 Imara reports Q3 EPS (72c), consensus (80c) 08/14/20 Imara reports Q2 EPS (59c), consensus (56c) GTH Genetron $15.66 / +2.01 (+14.73%) 08/06/20 Genetron reports Q2 adjusted EPS (4c), consensus (9c) DKNG DraftKings $49.00 / +1.45 (+3.05%) 11/13/20 DraftKings sees 2021 revenue $750M-$850M, consensus $772.64M 11/13/20 DraftKings raises 2020 revenue view $540M-$560M from $500M-$540M 11/13/20 DraftKings reports Q3 EPS (98c), consensus (61c) 11/12/20 Notable companies reporting before tomorrow's open CHNG Change Healthcare $23.72 / +5.475 (+30.01%) 11/04/20 Change Healthcare sees Q3 EPS 28c-33c, consensus 29c 11/04/20 Change Healthcare reports Q2 EPS 32c, consensus 25c 11/04/20 Notable companies reporting after market close 09/09/20 Change Healthcare raises Q2 adj. EPS view to 24c-28c from 20c-23c, consensus 22c BABA Alibaba $227.58 / -12.84 (-5.34%) 11/05/20 Alibaba reports Q2 adjusted EPS $2.65, consensus $2.11 11/04/20 Notable companies reporting before tomorrow's open 08/20/20 Alibaba reports Q1 adjusted EPS $2.10, consensus $1.99 ABC AmerisourceBergen $106.15 / +8.43 (+8.63%) 01/06/21 AmerisourceBergen raises FY21 EPS view to $8.25-$8.50, consensus $8.41 11/05/20 AmerisourceBergen sees FY21 adjusted EPS $8.20-$8.45, consensus $8.42 11/05/20 AmerisourceBergen reports Q4 adjusted EPS $1.89, consensus $1.85 07 Jan 07 Oct 07 Aug 19 Jun 19 Jun 19 May 30 Apr 12 Mar 14 Feb 12 Feb WBA UNH TSLA TCEHY MRNA DKNG CHL CHA BABA ABC WBA Walgreens Boots Alliance $43.05 / +1.89 (+4.59%) 12/20/20 CDC panel says frontline workers, people over 74 should be next, NYTimes reports 11/01/20 CVS, Walgreens among pharmacies set to give COVID vaccines, Bloomberg says 10/23/20 HHS says thousands of facilities opt into CVS, Walgreens vaccine deal, CNBC says 10/16/20 White House in vaccine administration deal with CVS, Walgreens, Politico reports UNH UnitedHealth $359.37 / +14.85 (+4.31%) 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says 10/01/20 Insurers reduce coverage for virtual doctors' visits, WSJ reports 09/29/20 UnitedHealth buys DivvyDose, a rival of Amazon's PillPack, CNBC says TSLA Tesla $756.20 / +20.72 (+2.82%) 01/06/21 NIO plans to launch models with lithium iron phosphate batteries, CNEVPost says 01/05/21 Tesla chargers pulled from Emart, Shinsegae branches, JoongAng Daily says 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says 01/05/21 Tesla to buy batteries from Panasonic until at least 2022, Nikkei reports TCEHY Tencent $0.00 / + (+0.00%) 12/15/20 Baidu considering making its own electric vehicles, Reuters reports 12/14/20 Alibaba, others fined for not reporting deals to Chinese regulators, CNBC says 11/27/20 Alibaba, Tencent put talks to buy control of iQIYI on hold, Reuters reports MRNA Moderna $116.27 / +7.25 (+6.65%) 01/05/21 Moderna, NIH studying if cutting doses can double vaccine supply, NYT says 01/03/21 U.S. may cut some Moderna COVID vaccine doses in half, Reuters reports 12/30/20 Texas shipments of Moderna vaccine delayed over temperature, Bloomberg says 12/27/20 Europe launches mass COVID-19 vaccination, Reuters reports DKNG DraftKings $49.00 / +1.45 (+3.05%) 01/06/21 Cuomo to add mobile sports betting to policy proposals, NY Daily News says 12/18/20 Ohio sports betting bill fails to reach Senate floor, Play Ohio reports 12/09/20 NY online sports betting could soon be legal, PlayNY says 11/16/20 NCAA in talks to host entire 68-team basketball tournament, AP reports CHL China Mobile $27.70 / -1.65 (-5.62%) 09/16/20 Alibaba, China Mobile mull $443M investment in Dahua, Reuters reports CHA China Telecom $28.85 / +0.33 (+1.16%) 01/05/21 NYSE mulls reverting to prior plan to delist China shares, Bloomberg says 01/05/21 Mnuchin disagrees with NYSE reversal on Chinese stock decision, Bloomberg says 11/12/20 White House to prohibit U.S. investments in some Chinese firms, Reuters says BABA Alibaba $227.58 / -12.84 (-5.34%) 01/06/21 U.S. weighs adding Alibaba, Tencent to China investment blacklist, WSJ reports 01/05/21 Trump orders ban on transactions with 8 Chinese apps, incl. Alipay, Reuters says 01/05/21 Chinese regulators request Ant Group share consumer data, WSJ says 01/05/21 Alibaba founder Jack Ma is not missing, CNBC reports ABC AmerisourceBergen $106.15 / +8.43 (+8.63%) 11/05/20 Distributors and J&J closing in on $26B opioid settlement deal, NY Times says 09/24/20 U.S. appeals court rejects novel opioid settlement framework, Reuters says 08/18/20 States seeking $26.4B from pharma companies in opioid litigation, WSJ reports WBA UNH TSLA TCEHY NEO MRNA GTH DKNG CHNG BABA ABC WBA Walgreens Boots Alliance $43.05 / +1.89 (+4.59%) 11/17/20 Fly Intel: Wall Street's top stories at midday UNH UnitedHealth $359.37 / +14.85 (+4.31%) 12/01/20 Fly Intel: Wall Street's top stories for Tuesday TSLA Tesla $756.20 / +20.72 (+2.82%) 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street TCEHY Tencent $0.00 / + (+0.00%) 01/05/21 Game On: Nintendo buys 'Luigi's Mansion 3' developer Next Level Games 12/22/20 Game On: Sony pulls buggy 'Cyberpunk 2077' from PS Store 12/15/20 Game On: NPD reports 35% year-over-year jump in November gaming spending NEO NeoGenomics $51.35 / -3.47 (-6.33%) 01/05/21 Fly Intel: After-Hours Movers MRNA Moderna $116.27 / +7.25 (+6.65%) 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday GTH Genetron $15.66 / +2.01 (+14.73%) 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/30/20 Fly Intel: Wall Street's top stories at midday DKNG DraftKings $49.00 / +1.45 (+3.05%) 01/06/21 DraftKings rises on Gov. Cuomo's endorsement of mobile betting in NY 12/31/20 Bet On It: Rush Street Interactive completes SPAC merger, exceeds expectations 12/18/20 Bet On It: New Jersey tops U.S. sports betting again as Ohio bill stalls CHNG Change Healthcare $23.72 / +5.475 (+30.01%) 07/14/20 UnitedHealth's new diabetes service not seen impacting Livongo near-term BABA Alibaba $227.58 / -12.84 (-5.34%) 12/28/20 Fly Intel: Wall Street's top stories for Monday 12/28/20 Fly Intel: Pre-market Movers 12/24/20 Fly Intel: Wall Street's top stories for Thursday ABC AmerisourceBergen $106.15 / +8.43 (+8.63%) 01/06/21 Fly Intel: Pre-market Movers 11/17/20 Fly Intel: Wall Street's top stories for Tuesday 01/06/21 Economics & Strategy 01/12/21 Technology & Internet Virtual Conference 01/13/21 CES 2021 01/06/21 AmerisourceBergen - ABC 01/07/21 Walgreens Boots Alliance - WBA 01/20/21 UnitedHealth - UNH 02/04/21 Change Healthcare - CHNG 02/04/21 AmerisourceBergen - ABC 01/22/21 Mapping Your Corporate Social Responsibility 01/19/21 Genetron 01/20/21 Genetron 01/28/21 Walgreens Boots Alliance Inc WBA UNH TSLA MRNA DKNG CHNG CHL BABA ABC WBA Walgreens Boots Alliance $43.05 / +1.89 (+4.59%) 12/31/20 Walgreen Boots call volume above normal and directionally bullish 12/07/20 Unusually active option classes on open December 7th 12/04/20 Unusually active option classes on open December 4th 12/03/20 Walgreen Boots call volume above normal and directionally bullish UNH UnitedHealth $359.37 / +14.85 (+4.31%) 10/14/20 Unusually active option classes on open October 14th 07/15/20 Unusually active option classes on open July 15th TSLA Tesla $756.20 / +20.72 (+2.82%) 01/05/21 Notable open interest changes for January 5th 01/04/21 Notable open interest changes for January 4th 12/22/20 Notable open interest changes for December 22nd MRNA Moderna $116.27 / +7.25 (+6.65%) 12/17/20 Moderna call volume above normal and directionally bullish 11/27/20 Moderna call buyer realizes 22% same-day gains 11/25/20 Moderna call volume above normal and directionally bullish 11/13/20 Unusually active option classes on open November 13th DKNG DraftKings $49.00 / +1.45 (+3.05%) 12/18/20 DraftKings call buyer realizes 23% same-day gains 12/07/20 Largest borrow rate increases among liquid names 11/25/20 DraftKings call volume above normal and directionally bullish CHNG Change Healthcare $23.72 / +5.475 (+30.01%) 11/04/20 Unusual call flow in option market yesterday 11/03/20 Call buyer in Change Healthcare opens 17-day upside earnings/election play 07/31/20 Change Healthcare call volume above normal and directionally bullish CHL China Mobile $27.70 / -1.65 (-5.62%) 01/05/21 Unusually active option classes on open January 5th 07/13/20 Unusually active option classes on open July 13th BABA Alibaba $227.58 / -12.84 (-5.34%) 12/31/20 Notable open interest changes for December 31st 12/30/20 Unusually active option classes on open December 30th 12/30/20 Notable open interest changes for December 30th 12/30/20 Alibaba call buyer realizes 9% same-day gains ABC AmerisourceBergen $106.15 / +8.43 (+8.63%) 01/06/21 Early notable gainers among liquid option names on January 6th 10/15/20 Early notable gainers among liquid option names on October 15th

On The Fly

Fly Intel: Wall Street's top stories at midday » 12:38

01/06/21

01/06

12:38

01/06/21

12:38

MRNA

Moderna

$114.39 / +5.37 (+4.93%)

, CHA

China Telecom

$26.91 / -1.61 (-5.65%)

, CHL

China Mobile

$27.70 / -1.65 (-5.62%)

, CHU

China Unicom

$6.10 / -0.05 (-0.81%)

, ABC

AmerisourceBergen

$105.02 / +7.3 (+7.47%)

, WBA

Walgreens Boots Alliance

$42.92 / +1.76 (+4.28%)

, UNH

UnitedHealth

$347.00 / +2.48 (+0.72%)

, CHNG

Change Healthcare

$23.86 / +5.61 (+30.75%)

, TSLA

Tesla

$773.11 / +37.63 (+5.12%)

, GTH

Genetron

$16.14 / +2.49 (+18.24%)

, DNMR

Danimer Scientific

$26.28 / +3.63 (+16.03%)

, IMRA

Imara

$15.30 / -8.44 (-35.55%)

, NEO

NeoGenomics

$49.40 / -5.42 (-9.89%)

Stock futures were mostly…

Open Full Text

ShowHide Related Items >><<

Company News
Street Research
Earnings
Syndicate
Periodicals
On The Fly
Events
Options

WBA
UNH
TSLA
NEO
MRNA
IMRA
GTH
DNMR
CHU
CHNG
CHL
CHA
ABC

WBA Walgreens Boots Alliance

$42.92 / +1.76 (+4.28%)

UNH UnitedHealth

$347.00 / +2.48 (+0.72%)

TSLA Tesla

$773.11 / +37.63 (+5.12%)

NEO NeoGenomics

$49.40 / -5.42 (-9.89%)

MRNA Moderna

$114.39 / +5.37 (+4.93%)

IMRA Imara

$15.30 / -8.44 (-35.55%)

GTH Genetron

$16.14 / +2.49 (+18.24%)

DNMR Danimer Scientific

$26.28 / +3.63 (+16.03%)

CHU China Unicom

$6.10 / -0.05 (-0.81%)

CHNG Change Healthcare

$23.86 / +5.61 (+30.75%)

CHL China Mobile

$27.70 / -1.65 (-5.62%)

CHA China Telecom

$26.91 / -1.61 (-5.65%)

ABC AmerisourceBergen

$105.02 / +7.3 (+7.47%)

MRNA
CHA
CHL
CHU
ABC
WBA
UNH
CHNG
TSLA
GTH
DNMR
IMRA
NEO

MRNA Moderna

$114.39 / +5.37 (+4.93%)

01/04/21 Piper Sandler: Moderna shares warrant 'fresh look' after 41% pullback, says Piper Sandler

12/31/20 Ladenburg: UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg

12/29/20 Citi: Arcturus selloff brings 'very good' buying opportunity, says Citi

12/24/20 Piper Sandler: Piper calls Inovio's COVID vaccine candidate 'an also-ran' after data published

CHA China Telecom

$26.91 / -1.61 (-5.65%)

03/24/20 CLSA: China Telecom upgraded to Outperform from Underperform at CLSA

03/24/20 Macquarie: China Telecom upgraded to Outperform from Neutral earlier at Macquarie

CHL China Mobile

$27.70 / -1.65 (-5.62%)

07/13/20 New Street: China Mobile downgraded to Reduce from Neutral at New Street

03/19/20 New Street: China Mobile upgraded to Buy from Reduce at New Street

CHU China Unicom

$6.10 / -0.05 (-0.81%)

09/30/20 Nomura: China Unicom upgraded to Buy from Neutral at Nomura

03/23/20 Macquarie: China Unicom upgraded to Outperform from Neutral at Macquarie

03/23/20 Credit Suisse: China Unicom upgraded to Outperform from Neutral at Credit Suisse

03/23/20 Credit Suisse: China Unicom upgraded to Outperform from Neutral at Credit Suisse

ABC AmerisourceBergen

$105.02 / +7.3 (+7.47%)

01/06/21 BofA: AmerisourceBergen upgraded to Neutral from Underperform at BofA

11/18/20 Jefferies: Drug distributors' pullback on Amazon news an overreaction, says Jefferies

11/17/20 Goldman Sachs: Goldman says Amazon news likely to pressure entire pharmacy supply chain

11/13/20 Mizuho: AmerisourceBergen price target raised to $104 from $100 at Mizuho

WBA Walgreens Boots Alliance

$42.92 / +1.76 (+4.28%)

01/05/21 Truist: Walgreens Boots Alliance price target raised to $44 from $40 at Truist

12/04/20 Credit Suisse: Walgreens leverage buyout math 'could still work,' says Credit Suisse

11/17/20 Oppenheimer: Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer

UNH UnitedHealth

$347.00 / +2.48 (+0.72%)

01/06/21 Raymond James: Change Healthcare downgraded to Market Perform from Strong Buy at Raymond James

01/06/21 Piper Sandler: Change Healthcare price target raised to $25.75 from $23 at Piper Sandler

01/06/21 William Blair: Change Healthcare downgraded to Market Perform from Outperform at William Blair

01/05/21 Truist: UnitedHealth price target raised to $420 from $400 at Truist

CHNG Change Healthcare

$23.86 / +5.61 (+30.75%)

01/06/21 Baird: Change Healthcare downgraded to Neutral from Outperform at Baird

TSLA Tesla

$773.11 / +37.63 (+5.12%)

01/06/21 Credit Suisse: Credit Suisse upgrades Li Auto to Outperform on sales momentum, autonomous plans

01/05/21 Morgan Stanley: Tesla price target raised to $810 from $540 at Morgan Stanley

01/05/21: Fly Intel: Top five analyst downgrades

01/05/21 Exane BNP Paribas: Exane downgrades Tesla to sell with $340 target on growing competition

GTH Genetron

$16.14 / +2.49 (+18.24%)

09/30/20 Canaccord: Genetron China opportunity understated with current valuation, says Canaccord

08/03/20 Canaccord: Genetron outlook positive ahead of results, says Canaccord

07/14/20 BTIG: Genetron initiated with a Buy at BTIG

DNMR Danimer Scientific

$26.28 / +3.63 (+16.03%)

01/06/21 Jefferies: Danimer Scientific initiated with a Buy at Jefferies

IMRA Imara

$15.30 / -8.44 (-35.55%)

01/06/21 SVB Leerink: Imara selloff a potential buying opportunity, says SVB Leerink

08/17/20: Fly Intel: Top five analyst upgrades

08/17/20 Citi: Imara upgraded to Buy from Neutral at Citi

06/30/20 Citi: Imara downgraded to Neutral from Buy at Citi

NEO NeoGenomics

$49.40 / -5.42 (-9.89%)

12/11/20 BTIG: NeoGenomics initiated with a Buy at BTIG

11/20/20 SVB Leerink: NeoGenomics price target raised to $50 from $47 at SVB Leerink

10/28/20 Needham: NeoGenomics price target raised to $46 from $39 at Needham

10/28/20 Craig-Hallum: NeoGenomics price target raised to $50 from $42 at Craig-Hallum

WBA
UNH
TSLA
NEO
MRNA
IMRA
GTH
CHNG
ABC

WBA Walgreens Boots Alliance

$42.92 / +1.76 (+4.28%)

UNH UnitedHealth

$347.00 / +2.48 (+0.72%)

TSLA Tesla

$773.11 / +37.63 (+5.12%)

NEO NeoGenomics

$49.40 / -5.42 (-9.89%)

MRNA Moderna

$114.39 / +5.37 (+4.93%)

IMRA Imara

$15.30 / -8.44 (-35.55%)

GTH Genetron

$16.14 / +2.49 (+18.24%)

CHNG Change Healthcare

$23.86 / +5.61 (+30.75%)

ABC AmerisourceBergen

$105.02 / +7.3 (+7.47%)

07

Jan
07

Aug
19

Jun
19

May
30

Apr
12

Mar
14

Feb
12

Feb

WBA
UNH
TSLA
MRNA
CHL
CHA
ABC

WBA Walgreens Boots Alliance

$42.92 / +1.76 (+4.28%)

UNH UnitedHealth

$347.00 / +2.48 (+0.72%)

TSLA Tesla

$773.11 / +37.63 (+5.12%)

MRNA Moderna

$114.39 / +5.37 (+4.93%)

CHL China Mobile

$27.70 / -1.65 (-5.62%)

CHA China Telecom

$26.91 / -1.61 (-5.65%)

ABC AmerisourceBergen

$105.02 / +7.3 (+7.47%)

WBA
UNH
TSLA
MRNA
GTH
CHNG
CHA
ABC

WBA Walgreens Boots Alliance

$42.92 / +1.76 (+4.28%)

UNH UnitedHealth

$347.00 / +2.48 (+0.72%)

TSLA Tesla

$773.11 / +37.63 (+5.12%)

MRNA Moderna

$114.39 / +5.37 (+4.93%)

GTH Genetron

$16.14 / +2.49 (+18.24%)

CHNG Change Healthcare

$23.86 / +5.61 (+30.75%)

CHA China Telecom

$26.91 / -1.61 (-5.65%)

ABC AmerisourceBergen

$105.02 / +7.3 (+7.47%)

WBA
UNH
TSLA
MRNA
CHNG
CHL
ABC

WBA Walgreens Boots Alliance

$42.92 / +1.76 (+4.28%)

UNH UnitedHealth

$347.00 / +2.48 (+0.72%)

TSLA Tesla

$773.11 / +37.63 (+5.12%)

MRNA Moderna

$114.39 / +5.37 (+4.93%)

CHNG Change Healthcare

$23.86 / +5.61 (+30.75%)

CHL China Mobile

$27.70 / -1.65 (-5.62%)

ABC AmerisourceBergen

$105.02 / +7.3 (+7.47%)

Hot Stocks

Genetron, CTTQ enter exclusive partnership agreement for HCCscreen » 05:08

01/06/21

01/06

05:08

01/06/21

05:08

GTH

Genetron

$13.65 / -0.03 (-0.22%)

Genetron and Chia Tai…

Genetron and Chia Tai Tianqing Pharmaceutical, or CTTQ, a subsidiary of Sino Biopharmaceutical, announced an exclusive strategic partnership agreement for HCCscreen, Genetron Health's blood-based early screening test for hepatocellular carcinoma, or HCC, in China. This partnership targets the hospital market in China, with a focus on combatting liver disease, and marks Genetron Health's third commercialization initiative of HCCscreen in the country. Under the agreement, the companies will work together exclusively to co-market and co-promote HCCscreen in the hospital market, covering designated territories in China. The parties intend to target high-risk individuals for HCC, which include HBV-positive carriers, as well as other liver disease patients. Genetron will pay CTTQ a promotional fee based on a percentage of revenues generated from the collaboration. Contingent on certain sales and other requirements, the exclusivity period is expected to last three years. As a result of the agreement, Genetron expects HCCscreen revenues to further accelerate in China.

ShowHide Related Items >><<

Company News
Street Research
Earnings
Syndicate
On The Fly
Events

GTH Genetron

$13.65 / -0.03 (-0.22%)

GTH Genetron

$13.65 / -0.03 (-0.22%)

09/30/20 Canaccord: Genetron China opportunity understated with current valuation, says Canaccord

08/03/20 Canaccord: Genetron outlook positive ahead of results, says Canaccord

07/14/20 BTIG: Genetron initiated with a Buy at BTIG

GTH Genetron

$13.65 / -0.03 (-0.22%)

19

Jun

GTH Genetron

$13.65 / -0.03 (-0.22%)

Over a quarter ago
Hot Stocks	Genetron says HCCscreen selected by NCC, Wuxi for public health initiative » 08:04 11/27/20 11/27 08:04 11/27/20 08:04 GTH Genetron $13.30 / +0.81 (+6.49%) Genetron Holdings… Genetron Holdings provided an update for HCCscreen, its blood-based early screening test for hepatocellular carcinoma in China. Led by the Wuxi municipal government and administered by the National Cancer Center in China, the "Liver Cancer Early Screening Comprehensive Prevention and Control Project" is a public health initiative. The goal of the Project is to increase the awareness of liver cancer early screening, and to become a pilot city model in China. For the Project, Wuxi has selected HCCscreen for local residents who are high-risk individuals for HCC, and is committed to administering 150,000 tests over a period of three years. Wuxi had entered into a small-scale collaboration agreement with Genetron Health in 2019, and the Project represents an expanded collaboration between the parties. Wuxi is a city in the southern part of Jiangsu Province in eastern China with a population of over six million people, and has emerged as a biopharma innovation hub in recent years. Separately, Genetron Health has formed a new operating center through a joint venture agreement with Wuxi, in which the parties will closely collaborate on advancing the liver cancer early screening market in China, through the adoption of HCCscreen. Under this joint venture agreement, both parties will contribute capital, and Genetron Health will own 90% of the joint venture. In addition to the commitment of using HCCscreen for its residents, Wuxi will also provide Genetron Health with other supportive measures including rental, R&D subsidies and tax benefits. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly GTH Genetron $13.30 / +0.81 (+6.49%) 10/22/20 Genetron signs licensing agreement with ImmuQuad Bio for residual cancer assays 09/30/20 Genetron receives Breakthrough Device designation for NGS test HCCscreen 09/25/20 Genetron, CStone Pharma launch trial in China for CDx test for avapritinib 09/16/20 Genetron and dMed partner in one-stop oncology drug development service GTH Genetron $13.30 / +0.81 (+6.49%) 09/30/20 Canaccord Genetron China opportunity understated with current valuation, says Canaccord 08/03/20 Canaccord Genetron outlook positive ahead of results, says Canaccord 07/14/20 BTIG Genetron initiated with a Buy at BTIG GTH Genetron $13.30 / +0.81 (+6.49%) 08/06/20 Genetron reports Q2 adjusted EPS (4c), consensus (9c) 19 Jun GTH Genetron $13.30 / +0.81 (+6.49%) 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/30/20 Fly Intel: Wall Street's top stories at midday 09/16/20 Fly Intel: After-Hours Movers 06/21/20 Opening Day: Royalty Pharma jumps over 50% in largest IPO of 2020
Conference/Events	Canaccord to hold a virtual forum » 08:24 11/19/20 11/19 08:24 11/19/20 08:24 AFIB Acutus Medical $24.91 / -0.56 (-2.20%) , APYX Apyx Medical $7.02 / +0.04 (+0.57%) , ATRC AtriCure $40.81 / +0.46 (+1.14%) , AWH Aspira Women's Health $4.66 / +0.025 (+0.54%) , AXGN AxoGen $15.16 / -0.05 (-0.33%) , CSTL Castle Biosciences $46.27 / -2.05 (-4.24%) , GNMK GenMark $13.97 / +0.31 (+2.27%) , GTH Genetron $11.35 / -0.29 (-2.49%) , INMD InMode $42.75 / +0.16 (+0.38%) , KIDS OrthoPediatrics $44.84 / -1.55 (-3.34%) , LMAT LeMaitre $38.21 / -0.485 (-1.25%) , LUNG Pulmonx $46.50 / -0.07 (-0.15%) , NARI Inari Medical $65.75 / -2.08 (-3.07%) , PEN Penumbra $258.60 / -1.595 (-0.61%) , PODD Insulet $259.27 / -0.18 (-0.07%) , RCEL Avita Medical $22.80 / +0.09 (+0.40%) , SIEN Sientra $4.83 / + (+0.00%) , SPNE SeaSpine $14.01 / -0.05 (-0.36%) , TCMD Tactile Systems $43.95 / +1 (+2.33%) , TMDX TransMedics $14.17 / -0.33 (-2.28%) , XENT Intersect ENT $18.15 / -0.46 (-2.47%) , XGN Exagen $15.03 / -0.11 (-0.73%) 2020 Medical Technologies… 2020 Medical Technologies & Diagnostics Virtual Forum will be held on November 19. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XGN XENT TMDX TCMD SPNE SIEN RCEL PODD PEN NARI LMAT KIDS INMD GTH GNMK CSTL AXGN AWH ATRC APYX AFIB XGN Exagen $15.03 / -0.11 (-0.73%) 11/16/20 Exagen extends collaboration agreement with GlaxoSmithKline 11/02/20 Exagen to evaluate emergence of autoimmune diseases after COVID-19 10/12/20 Exagen provides data evaluating 'economic benefits AVISE Lupus testing' 09/29/20 Exagen announces agreement with Provider Network of America for AVISE tests XENT Intersect ENT $18.15 / -0.46 (-2.47%) 11/17/20 Intersect ENT announces new leadership appointments 09/15/20 Intersect ENT agrees to acquire Fiagon AG Medical Technologies for EUR 60M 09/15/20 Intersect ENT agrees to acquire Fiagon AG Medical Technologies for EUR 60M 09/10/20 Intersect ENT signs Sinuva distribution agreement with AllianceRx Walgreens TMDX TransMedics $14.17 / -0.33 (-2.28%) 09/28/20 FDA postpones advisory committee meeting to review TransMedics OCS Heart 05/26/20 TransMedics announces results from U.S. OCS Liver PROTECT trial TCMD Tactile Systems $43.95 / +1 (+2.33%) 05/21/20 Tactile Systems names Daniel Reuvers as new CEO SPNE SeaSpine $14.01 / -0.05 (-0.36%) 11/03/20 SeaSpine announces publication of results from cellular bone graft study 09/23/20 SeaSpine commercially launches WaveForm C Interbody Implant System 09/23/20 SeaSpine announces limited commercial launch of WaveForm C by mid 2021 08/11/20 SeaSpine announces limited commercial launch of Explorer TO System SIEN Sientra $4.83 / + (+0.00%) 11/09/20 Sientra names Ron Menezes CEO, Jeffrey Nugent to retire 08/25/20 Sientra receives regulatory approval to market Opus implants in Japan RCEL Avita Medical $22.80 / +0.09 (+0.40%) 11/09/20 Avita Medical enters collaboration with Houston Methodist Research Institute 11/06/20 Avita Medical announces CFO David McIntyre to resign 11/05/20 Avita Medical corrects time for adjourned 2020 Annual Stockholder Meeting 09/14/20 AVITA Therapeutics enrolls first patient in RECELL System pivotal study PODD Insulet $259.27 / -0.18 (-0.07%) 09/21/20 Insulet launches Omnipod DASH System in additional countries 06/05/20 Insulet resumes pivotal study of Omnipod, Powered by Horizon PEN Penumbra $258.60 / -1.595 (-0.61%) 11/10/20 Penumbra enters partnership with RapidAI to develop modules for PE 10/29/20 Penumbra rises 13.7% 10/29/20 Penumbra rises 11.5% NARI Inari Medical $65.75 / -2.08 (-3.07%) 11/13/20 Inari Medical presents 30-day follow-up results from FLASH study 10/19/20 Inari Medical announces presentation of results from real world FLASH registry 09/21/20 Inari says interim results from the FLASH study to be presented at TCT Connect 09/17/20 Inari Medical announces promotion of Drew Hykes to COO LMAT LeMaitre $38.21 / -0.485 (-1.25%) 11/02/20 LeMaitre CEO sells 93K shares of common stock 06/22/20 LeMaitre Vascular acquires Artegraft for $90M KIDS OrthoPediatrics $44.84 / -1.55 (-3.34%) 09/03/20 OrthoPediatrics announces 1,000th procedure utilizing PNP FEMUR system 08/03/20 OrthoPediatrics achieves 500th case with FIREFLY navigation guides 06/10/20 OrthoPediatrics commences U.S. launch of ApiFix system INMD InMode $42.75 / +0.16 (+0.38%) 11/11/20 InMode granted U.S. patent for fractional radiofrequency technology Morpues8 09/02/20 InMode authorizes share repurchase program of up to 1 million shares 07/06/20 InMode announces NMPA approval for 2 InMode platforms in China GTH Genetron $11.35 / -0.29 (-2.49%) 10/22/20 Genetron signs licensing agreement with ImmuQuad Bio for residual cancer assays 09/30/20 Genetron receives Breakthrough Device designation for NGS test HCCscreen 09/25/20 Genetron, CStone Pharma launch trial in China for CDx test for avapritinib 09/16/20 Genetron and dMed partner in one-stop oncology drug development service GNMK GenMark $13.97 / +0.31 (+2.27%) 10/08/20 GenMark ePlex RP2 test receives EUA from FDA 09/14/20 GenMark's Diagnostics' ePlex respiratory pathogen panel 2 achieves CE mark 06/29/20 GenMark announces commercial launch of ePlex Respiratory Pathogen Panel 2 06/16/20 GenMark chosen as primary provider of rapid diagnostic testing for Vidant CSTL Castle Biosciences $46.27 / -2.05 (-4.24%) 11/17/20 Castle Biosciences announces publication of two studies in SKIN 11/12/20 Castle Biosciences presents data for melanoma tests at ASDP 11/02/20 Castle Biosciences announces commercial availability of DiffDx-Melanoma 10/08/20 Castle Biosciences announces expanded Medicare coverage for DecisionDx-Melanoma AXGN AxoGen $15.16 / -0.05 (-0.33%) 07/22/20 AxoGen RECON study completes target enrollment of 220 subjects 07/01/20 AxoGen announces seven-year financing agreement with Oberland Capital 06/01/20 Axogen general counsel Greg Freitag retires AWH Aspira Women's Health $4.66 / +0.025 (+0.54%) 11/19/20 Aspira Women's Health enters collaborative agreement with Baylor Genetics 11/10/20 Aspira Women's Health names Kaile Zagger As COO 11/09/20 Aspira Women's Health appoints Sandra Brooks to board of directors 10/14/20 Aspira Women's Health becomes Anthem BlueCross BlueShield Georgia provider ATRC AtriCure $40.81 / +0.46 (+1.14%) 08/06/20 AtriCure names Angie Wirick CFO APYX Apyx Medical $7.02 / +0.04 (+0.57%) 10/20/20 Apyx Medical announces two peer-reviewed publications on Helium Plasma 06/22/20 Apyx Medical approved to sell Helium Plasma products in 5 new countries AFIB Acutus Medical $24.91 / -0.56 (-2.20%) 09/17/20 Acutus announces FDA clearance of 2nd generation AcQMap 3D catheter 09/08/20 Acutus Medical announces pulse field ablation program, pre-clinical results 08/20/20 James Flynn reports 17.14% stake in Acutus Medical AFIB APYX ATRC AWH AXGN CSTL GNMK GTH INMD KIDS LMAT LUNG NARI PEN PODD RCEL SIEN SPNE TCMD TMDX XENT XGN AFIB Acutus Medical $24.91 / -0.56 (-2.20%) 08/31/20 Fly Intel: Top five analyst initiations 08/31/20 JPMorgan Acutus Medical initiated with an Overweight at JPMorgan 08/31/20 William Blair Acutus Medical initiated with an Outperform at William Blair 08/31/20 BTIG Acutus Medical initiated with a Buy at BTIG APYX Apyx Medical $7.02 / +0.04 (+0.57%) 06/22/20 Piper Sandler Apyx Medical's expanded international sale 'important', says Piper Sandler 03/17/20 Piper Sandler Apyx Medical price target lowered to $7 from $10 at Piper Sandler 01/13/20 JMP Securities Apyx Medical shares likely to continue to appreciate, says JMP Securities ATRC AtriCure $40.81 / +0.46 (+1.14%) 11/12/20 JPMorgan JPMorgan a buyer of AtriCure ahead of 'major catalyst' 09/30/20 Piper Sandler Piper Sandler 'highly' recommends five names in Medical Technology 07/29/20 SVB Leerink AtriCure price target raised to $60 from $55 at SVB Leerink 07/29/20 Piper Sandler AtriCure price target raised to $50 from $47 at Piper Sandler AWH Aspira Women's Health $4.66 / +0.025 (+0.54%) 10/29/20 William Blair Aspira Women's Health initiated with an Outperform at William Blair AXGN AxoGen $15.16 / -0.05 (-0.33%) 10/22/20 Guggenheim AxoGen initiated with a Buy at Guggenheim 06/16/20 Cantor Fitzgerald AxoGen assumed with an Overweight at Cantor Fitzgerald 06/15/20 Cantor Fitzgerald AxoGen assumed with an Overweight at Cantor Fitzgerald 05/07/20 Canaccord AxoGen downgraded to Hold at Canaccord CSTL Castle Biosciences $46.27 / -2.05 (-4.24%) 11/09/20 KeyBanc Castle Biosciences initiated with an Overweight at KeyBanc 10/13/20 Canaccord Castle Biosciences price target raised to $61 from $52 at Canaccord 09/25/20 SVB Leerink Castle Biosciences price target raised to $57 from $50 at SVB Leerink 09/03/20 Canaccord Castle Biosciences price target raised to $52 from $47 at Canaccord GNMK GenMark $13.97 / +0.31 (+2.27%) 10/09/20 Canaccord Execution positions GenMark for long-term success, says Canaccord 08/28/20 Canaccord Hospital service channel shares weakness a buying opportunity, says Canaccord 08/05/20 Canaccord GenMark price target raised to $22 from $20 at Canaccord 07/08/20 BTIG GenMark price target raised to $18 from $14 at BTIG GTH Genetron $11.35 / -0.29 (-2.49%) 09/30/20 Canaccord Genetron China opportunity understated with current valuation, says Canaccord 08/03/20 Canaccord Genetron outlook positive ahead of results, says Canaccord 07/14/20 BTIG Genetron initiated with a Buy at BTIG INMD InMode $42.75 / +0.16 (+0.38%) 10/21/20 Canaccord InMode price target raised to $51 from $42 at Canaccord 10/13/20 Baird InMode price target raised to $55 from $43 at Baird 02/19/20 Barclays InMode price target raised to $48 from $45 at Barclays 01/28/20 Baird InMode price target raised to $55 from $45 at Baird KIDS OrthoPediatrics $44.84 / -1.55 (-3.34%) 10/07/20 BTIG OrthoPediatrics price target raised to $57 from $54 at BTIG 08/06/20 Piper Sandler Piper says OrthoPediatrics can win in 'more muted competitive environment' 08/06/20 Needham OrthoPediatrics price target raised to $57 from $49 at Needham 06/23/20 Piper Sandler OrthoPediatrics recovery better than expected, says Piper Sandler LMAT LeMaitre $38.21 / -0.485 (-1.25%) 10/30/20 Barrington LeMaitre price target raised to $46 from $36 at Barrington 10/28/20 Barrington Varian Medical downgraded to Underperform from Outperform at Barrington 07/24/20 Lake Street LeMaitre price target raised to $38 from $33 at Lake Street 05/04/20 Roth Capital LeMaitre price target lowered to $28 from $32.50 at Roth Capital LUNG Pulmonx $46.50 / -0.07 (-0.15%) 10/26/20 BofA Pulmonx initiated with a Buy at BofA 10/26/20 Canaccord Pulmonx initiated with a Buy at Canaccord 10/26/20 Morgan Stanley Pulmonx initiated with an Equal Weight at Morgan Stanley 10/26/20 Stifel Pulmonx initiated with a Buy at Stifel NARI Inari Medical $65.75 / -2.08 (-3.07%) 11/18/20 Fly Intel: Top five analyst initiations 11/18/20 BTIG Inari Medical initiated with a Buy at BTIG 11/13/20 SVB Leerink Inari Medical price target raised to $90 from $80 at SVB Leerink 10/29/20 Morgan Stanley Morgan Stanley upgrades Inari Medical on 'clear signs' of VTE inflection PEN Penumbra $258.60 / -1.595 (-0.61%) 10/29/20 Canaccord Penumbra price target raised to $292 from $253 at Canaccord 10/29/20 Wells Fargo Penumbra price target raised to $265 from $255 at Wells Fargo 10/29/20 JPMorgan JPMorgan ups Penumbra target, reiterates as top pick into 2021 PODD Insulet $259.27 / -0.18 (-0.07%) 11/05/20 Wells Fargo Insulet price target raised to $266 from $250 at Wells Fargo 11/03/20 Piper Sandler Clinical Trials update positive for Insulet, says Piper Sandler 10/16/20 Citi Citi opens 'positive catalyst watch' on DexCom 08/11/20 Piper Sandler Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler RCEL Avita Medical $22.80 / +0.09 (+0.40%) 08/27/20 Fly Intel: Top five analyst initiations 08/27/20 BofA Avita Medical assumed with a Buy at BofA 07/09/20 BTIG Avita Medical price target raised to $41 from $8 at BTIG 07/06/20 Oppenheimer Avita Medical price target raised to $45 from $9 at Oppenheimer SIEN Sientra $4.83 / + (+0.00%) 10/08/20 Stifel Stifel sees upside potential for Sientra after survey of aesthetics doctors 06/11/20 Maxim Sientra price target raised to $8 from $5 at Maxim 03/12/20 Craig-Hallum Sientra price target lowered to $9 from $14 at Craig-Hallum 03/12/20 SVB Leerink Sientra price target lowered to $6.50 from $13 at SVB Leerink SPNE SeaSpine $14.01 / -0.05 (-0.36%) 10/19/20 Stifel SeaSpine initiated with a Buy at Stifel 10/06/20 Piper Sandler SeaSpine remains 'must-own SMID-cap name,' says Piper Sandler 08/05/20 Piper Sandler SeaSpine remains 'must own SMID name' at Piper Sandler 06/16/20 Cantor Fitzgerald SeaSpine assumed with an Overweight at Cantor Fitzgerald TCMD Tactile Systems $43.95 / +1 (+2.33%) 11/13/20 Oppenheimer Tactile Systems upgraded to Outperform from Perform at Oppenheimer 11/13/20 Oppenheimer Tactile Systems upgraded to Outperform from Perform at Oppenheimer 11/03/20 Piper Sandler Tactile Systems shares still recommended after results at Piper Sandler TMDX TransMedics $14.17 / -0.33 (-2.28%) 10/08/20 Fly Intel: Top five analyst downgrades 10/08/20 JPMorgan TransMedics downgraded to Neutral on 'missed' execution at JPMorgan 10/08/20 JPMorgan TransMedics downgraded to Neutral from Overweight at JPMorgan 09/29/20 Canaccord TransMedics story intact despite OCS Heart delay, says Canaccord XENT Intersect ENT $18.15 / -0.46 (-2.47%) 11/19/20 BTIG Intersect ENT upgraded to Buy from Neutral at BTIG 11/02/20 Piper Sandler Intersect ENT price target raised to $17 from $16 at Piper Sandler 10/22/20 Piper Sandler Intersect ENT price target lowered to $16 from $17 at Piper Sandler 10/15/20 Piper Sandler Intersect ENT shares may be pressured by below-consensus Q4, says Piper Sandler XGN Exagen $15.03 / -0.11 (-0.73%) 11/09/20 KeyBanc Exagen initiated with an Overweight at KeyBanc 10/07/20 BTIG Exagen assumed with a Buy at BTIG 06/02/20 Cantor Fitzgerald Exagen assumed with an Overweight at Cantor Fitzgerald 06/01/20 Cantor Fitzgerald Exagen assumed with an Overweight at Cantor Fitzgerald XGN XENT TMDX TCMD SPNE SIEN PODD PEN NARI LMAT KIDS INMD GTH GNMK CSTL AXGN ATRC APYX AFIB XGN Exagen $15.03 / -0.11 (-0.73%) 11/10/20 Exagen reports Q3 EPS (34c), consensus (48c) 07/28/20 Exagen reports Q2 EPS (27c), consensus (76c) XENT Intersect ENT $18.15 / -0.46 (-2.47%) 11/02/20 Intersect ENT reports Q3 EPS (35c), consensus (45c) 10/15/20 Intersect ENT sees Q4 revenue about 85%-90% of Q4 in FY19 10/15/20 Intersect ENT sees Q3 revenue $22.4M-$22.8M, consensus $21.4M 08/04/20 Intersect ENT reports Q2 adj. EPS (65c), consensus (56c) TMDX TransMedics $14.17 / -0.33 (-2.28%) 11/04/20 TransMedics reports Q3 EPS (19c), consensus (32c). 08/05/20 TransMedics reports Q2 EPS (36c), consensus (42c) TCMD Tactile Systems $43.95 / +1 (+2.33%) 08/03/20 Tactile Systems reports Q2 EPS (72c), consensus (22c) SPNE SeaSpine $14.01 / -0.05 (-0.36%) 11/09/20 SeaSpine reports Q3 EPS (24c), consensus (31c) 10/06/20 SeaSpine sees Q4 revenue $47M-$48M, consensus $45.14M 10/06/20 SeaSpine sees Q3 revenue $42.9M-$43.3M, consensus $39.48M 08/04/20 SeaSpine does not update withdrawn 2020 guidance SIEN Sientra $4.83 / + (+0.00%) 11/09/20 Sientra sees FY20 revenue $63M-$66M, consensus $61.31M 11/09/20 Sientra reports Q3 EPS (12c), consensus (36c) 08/10/20 Sientra reports Q2 EPS (68c), consensus (43c) PODD Insulet $259.27 / -0.18 (-0.07%) 11/04/20 Insulet raises FY20 revenue growth guidance to 20%-21% from 17%-19% 11/04/20 Insulet reports Q3 EPS 17c, consensus 8c 08/06/20 Insulet raises 2020 revenue growth to 17%-19% from 15% 08/06/20 Insulet sees Q3 revenue growth 13%-15% PEN Penumbra $258.60 / -1.595 (-0.61%) 10/28/20 Penumbra reports Q3 non-GAAP EPS 6c, consensus (8c) 08/03/20 Penumbra reports Q2 EPS (34c), consensus (39c) NARI Inari Medical $65.75 / -2.08 (-3.07%) 11/12/20 Inari Medical reports Q3 EPS 12c, consensus (4c) 08/11/20 Inari Medical reports Q2 EPS (16c), consensus (18c) LMAT LeMaitre $38.21 / -0.485 (-1.25%) 10/29/20 LeMaitre sees Q4 EPS 94c-$1.04, consensus 22c 10/29/20 LeMaitre reports Q3 EPS 37c, consensus 19c 07/23/20 LeMaitre sees Q3 EPS 17c-26c, consensus 8c 07/23/20 LeMaitre Vascular reports Q2 EPS 17c, consensus 1c KIDS OrthoPediatrics $44.84 / -1.55 (-3.34%) 08/05/20 OrthoPediatrics reports Q2 EPS (54c), consensus (38c) INMD InMode $42.75 / +0.16 (+0.38%) 11/12/20 InMode reports Q3 non-GAAP EPS 63c, consensus 48c 10/13/20 InMode sees FY20 revenue $192M-$195M, consensus $159.91M 10/13/20 InMode sees Q3 non-GAAP EPS 60c-62c, consensus 31c 08/05/20 InMode sees FY20 revenue $156M-$160M, consensus $143.04M GTH Genetron $11.35 / -0.29 (-2.49%) 08/06/20 Genetron reports Q2 adjusted EPS (4c), consensus (9c) GNMK GenMark $13.97 / +0.31 (+2.27%) 10/28/20 GenMark raises FY20 revenue view to $165M-$168M from $155M-$165M 10/28/20 GenMark reports Q3 EPS (5c), consensus (6c) 10/08/20 GenMark reports preliminary Q3 revenue $42.6M, consensus $38.09M 08/04/20 GenMark boosts FY20 revenue view to $155M-165M from $120M-$130M CSTL Castle Biosciences $46.27 / -2.05 (-4.24%) 11/09/20 Castle Biosciences reports Q3 EPS (23c), consensus (11c) 08/10/20 Castle Biosciences reports Q2 EPS (8c), consensus (40c) AXGN AxoGen $15.16 / -0.05 (-0.33%) 10/29/20 AxoGen reports Q3 EPS 4c, consensus (14c) 08/05/20 AxoGen reports Q2 EPS (20c), consensus (38c) 07/01/20 AxoGen sees Q3, Q4 revenue below prior-year levels 07/01/20 AxoGen sees Q2 revenue at least $21M, cosensus $11.67M ATRC AtriCure $40.81 / +0.46 (+1.14%) 11/05/20 AtriCure sees Q4 revenue $56M-$60M, consensus $62.05M 11/05/20 AtriCure reports Q3 EPS (11c), consensus (34c) 07/28/20 AtriCure still not providing 2020 financial guidance 07/28/20 AtriCure reports Q2 adjusted EPS (38c), consensus (57c) APYX Apyx Medical $7.02 / +0.04 (+0.57%) 11/09/20 Apyx Medical reports Q3 EPS (11c), consensus (16c) 08/10/20 Apyx Medical not providing FY20 guidance 'at this time' 08/10/20 Apyx Medical reports Q2 EPS (14c), consensus (21c) AFIB Acutus Medical $24.91 / -0.56 (-2.20%) 11/12/20 Acutus Medical reports Q3 EPS ($1.95), consensus (99c) 09/17/20 Acutus Medical reports Q2 EPS ($32.24) vs ($45.70) last year 01 Oct 06 Aug 25 Jun 18 Jun 19 Jun 28 May 27 May 22 May 13 May 12 May 07 May 08 Jan 11 Dec XENT PEN ATRC XENT Intersect ENT $18.15 / -0.46 (-2.47%) 07/07/20 Intersect ENT reviewing Medtronic takeover offer, Bloomberg says 07/07/20 Medtronic makes bid to acquire Intersect ENT, Bloomberg says PEN Penumbra $258.60 / -1.595 (-0.61%) 11/10/20 Quintessential Capital issues short report on Penumbra with $55 target 11/10/20 Penumbra named short idea by Quintessential Capital 09/14/20 Penumbra could be made to address catheter failure, FFFJ reports ATRC AtriCure $40.81 / +0.46 (+1.14%) 09/30/20 Kerrisdale Captital short AtriCure, says Convergent 'doomed to fail' XENT TMDX SPNE PODD PEN NARI LUNG LMAT KIDS GTH GNMK CSTL AXGN APYX AFIB XENT Intersect ENT $18.15 / -0.46 (-2.47%) 07/08/20 Fly Intel: Wall Street's top stories for Wednesday 07/08/20 Fly Intel: Wall Street's top stories at midday TMDX TransMedics $14.17 / -0.33 (-2.28%) 05/27/20 Fly Intel: Pre-market Movers SPNE SeaSpine $14.01 / -0.05 (-0.36%) 10/19/20 Fly Intel: After-Hours Movers PODD Insulet $259.27 / -0.18 (-0.07%) 08/11/20 Medtronic rises following acquisition of insulin pen maker Companion PEN Penumbra $258.60 / -1.595 (-0.61%) 05/27/20 Fly Intel: After-Hours Movers NARI Inari Medical $65.75 / -2.08 (-3.07%) 05/24/20 Opening Day: SelectQuote goes public amid COVID-19, raises $360M in IPO LUNG Pulmonx $46.50 / -0.07 (-0.15%) 10/04/20 Opening Day: Palantir, Asana go public via direct listings LMAT LeMaitre $38.21 / -0.485 (-1.25%) 07/23/20 Fly Intel: After-Hours Movers KIDS OrthoPediatrics $44.84 / -1.55 (-3.34%) 06/17/20 Fly Intel: After-Hours Movers GTH Genetron $11.35 / -0.29 (-2.49%) 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/30/20 Fly Intel: Wall Street's top stories at midday 09/16/20 Fly Intel: After-Hours Movers 06/21/20 Opening Day: Royalty Pharma jumps over 50% in largest IPO of 2020 GNMK GenMark $13.97 / +0.31 (+2.27%) 10/28/20 Fly Intel: After-Hours Movers 10/09/20 Fly Intel: Pre-market Movers 10/08/20 Fly Intel: After-Hours Movers 07/07/20 Fly Intel: After-Hours Movers CSTL Castle Biosciences $46.27 / -2.05 (-4.24%) 06/22/20 Fly Intel: After-Hours Movers 06/22/20 Fly Insider: Generation Bio,Burlington among week's notable insider trades AXGN AxoGen $15.16 / -0.05 (-0.33%) 07/01/20 Fly Intel: Wall Street's top stories for Wednesday 07/01/20 Fly Intel: Wall Street's top stories at midday 07/01/20 Fly Intel: Pre-market Movers APYX Apyx Medical $7.02 / +0.04 (+0.57%) 06/23/20 Fly Intel: Pre-market Movers AFIB Acutus Medical $24.91 / -0.56 (-2.20%) 08/17/20 Fly Insider: Red Rock, CarGurus among week's notable insider trades 08/09/20 Opening Day: Quicken Loans parent raises only $1.8B in IPO 11/19/20 2020 Medical Technologies & Diagnostics Virtual Forum 12/08/20 LeMaitre TMDX NARI CSTL AWH TMDX TransMedics $14.17 / -0.33 (-2.28%) 09/02/20 Seven new option listings and two option delistings on September 2nd NARI Inari Medical $65.75 / -2.08 (-3.07%) 08/17/20 Two new option listings and one option delisting on August 17th CSTL Castle Biosciences $46.27 / -2.05 (-4.24%) 05/20/20 Six new option listings and three option delistings on May 20th AWH Aspira Women's Health $4.66 / +0.025 (+0.54%) 06/12/20 Two new option listings and two option delistings on June 12th
Conference/Events	Goldman Sachs to hold a virtual conference » 04:55 11/18/20 11/18 04:55 11/18/20 04:55 GTH Genetron $11.64 / -0.48 (-3.96%) , HCM Hutchison China MediTech $31.21 / +0.86 (+2.83%) , IMAB I-MAB $37.89 / +0.76 (+2.05%) Asia Pacific Healthcare… Asia Pacific Healthcare Virtual Forum 2020 will be held on November 16-18. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events IMAB HCM GTH IMAB I-MAB $37.89 / +0.76 (+2.05%) 11/11/20 I-MAB announces preclinical data on anti-C5aR antibody 11/09/20 I-MAB presents results from phase 1 clinical trial evaluating lemzoparlimab 09/30/20 I-MAB receives China CDE approval for Phase 3 trial of eftansomatropin 09/21/20 I-MAB announces China NMPA clearance for Phase 1 trial of lemzoparlimab HCM Hutchison China MediTech $31.21 / +0.86 (+2.83%) 09/20/20 Chi-Med highlights surufatinib Phase 3 results in neuroendocrine tumors at ESMO 09/17/20 Hutchison China MediTech's surufatinib granted second NDA in China 09/04/20 Chi-Med initiates FRESCO-2 Phase III registration study of fruquintinib 09/03/20 Chi-Med initiates Phase II study of HMPL-453 GTH Genetron $11.64 / -0.48 (-3.96%) 10/22/20 Genetron signs licensing agreement with ImmuQuad Bio for residual cancer assays 09/30/20 Genetron receives Breakthrough Device designation for NGS test HCCscreen 09/25/20 Genetron, CStone Pharma launch trial in China for CDx test for avapritinib 09/16/20 Genetron and dMed partner in one-stop oncology drug development service GTH HCM IMAB GTH Genetron $11.64 / -0.48 (-3.96%) 09/30/20 Canaccord Genetron China opportunity understated with current valuation, says Canaccord 08/03/20 Canaccord Genetron outlook positive ahead of results, says Canaccord 07/14/20 BTIG Genetron initiated with a Buy at BTIG HCM Hutchison China MediTech $31.21 / +0.86 (+2.83%) 10/02/20 Deutsche Bank Hutchison China MediTech initiated with a Buy at Deutsche Bank 03/13/20 Fly Intel: Top analyst initiations 03/12/20 Cantor Fitzgerald Hutchison China MediTech initiated with an Overweight at Cantor Fitzgerald 02/20/20 Fly Intel: Top five analyst initiations IMAB I-MAB $37.89 / +0.76 (+2.05%) 09/08/20 Cantor Fitzgerald I-MAB price target raised to $55 from $50 at Cantor Fitzgerald 07/27/20 Cantor Fitzgerald I-MAB initiated with an Overweight at Cantor Fitzgerald 02/14/20 Fly Intel: Top five analyst initiations 02/13/20 CICC I-MAB initiated with an Outperform at CICC HCM GTH HCM Hutchison China MediTech $31.21 / +0.86 (+2.83%) 08/10/20 Chi-Med plans to submit MAA for surufatinib following advice from CHMP 07/30/20 Chi-Med reports 1H20 revenue $106.8M vs. $102.2M last year GTH Genetron $11.64 / -0.48 (-3.96%) 08/06/20 Genetron reports Q2 adjusted EPS (4c), consensus (9c) 19 Jun 23 Jan 17 Jan IMAB GTH IMAB I-MAB $37.89 / +0.76 (+2.05%) 09/04/20 Fly Intel: Wall Street's top stories for Friday 09/04/20 Fly Intel: Wall Street's top stories at midday 05/27/20 Fly Intel: After-Hours Movers GTH Genetron $11.64 / -0.48 (-3.96%) 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/30/20 Fly Intel: Wall Street's top stories at midday 09/16/20 Fly Intel: After-Hours Movers 06/21/20 Opening Day: Royalty Pharma jumps over 50% in largest IPO of 2020 11/19/20 Asia Pacific Virtual Summit 11/19/20 2020 Medical Technologies & Diagnostics Virtual Forum 12/06/20 62nd Virtual Annual Meeting of ASH 11/18/20 Hutchison China MediTech 11/19/20 Hutchison China MediTech

20:25	Notable companies reporting before tomorrow's open»
13:18	Notable companies reporting before tomorrow's open»
13:17	Notable companies reporting after market close»
09:55	Fly Intel: Top five analyst initiations»
09:55	Fly Intel: Top five analyst downgrades»

DORM	Dorman Products - DORM
EVR	Evercore Partners - EVR
	2021 European Banks Virtual Conference
EXPO ...	2021 Technology, Internet & Services Virtual Conference
	Vehicle Technology & Mobility Virtual Conference 2021
	Media, Internet and Telecom Virtual Conference
	Global Property Virtual Conference
	GroceryShop Spring Meetup
	Global Financial Institutions Virtual Conference 2021
BBI ...	Global Life Sciences Virtual Conference

Get Full Fly Access